Possibilities of life quality correction of patients with chronic pancreatitis in postoperative hypothyroidis
https://doi.org/10.31146/1682-8658-ecg-195-11-21-27
Abstract
Aim: to study the quality of life and the emotional state of patients with chronic pancreatitis on the background of postoperative hypothyroidism and the possibility of effective rehabilitation.
Materials and methods. 270 patients with chronic pancreatitis were examined, among which 40 patients with primary postoperative hypothyroidism, who made up group 1, group 2 included 30 patients without thyroid pathology. Patients underwent a blood test according to the main biochemical parameters, hormonal blood count, ultrasound of the thyroid gland, hepatobiliary and duodenal zone. The study of quality of life and psychoemotional state by tests.
Results In patients with chronic pacreatitis in combination with postoperative hypothyroidism among diseases of the hepatoduodenal zone, chronic non-calculous cholecystitis and non-alcoholic fatty liver disease were identified that are clinically characterized by abdominal pain syndrome according to the GSRS questionnaire. Patients revealed mild depressive state, high levels of personal and situational anxiety. The quality of life of patients was reduced both in physical and in psychological components, due to indicators of role-playing physical and emotional functioning. Against the background of treatment with a combination of succinate-containing drugs, the severity of depression, situational and personal anxiety decreased, and role functioning due to physical and emotional state, social functioning increased.
Conclusions: The use of combination therapy with sodium levothyroxine and ethylmethylhydroxypyridine succinate in patients with comorbid pathology during postoperative hypothyroidism improves the clinical picture, psychoemotional balance and quality of life.
About the Authors
E. V. ChernyadevaRussian Federation
Elena V. Chernyadeva, postgraduate student in internal medicine
52, st. Promyshlennaya, Izhevsk
S. N. Styazhkina
Russian Federation
Svetlana N. Styazhkina, department of faculty surgery, professor, MD, PhD
281, st. Kommunarov, Republic of Udmurtia, Izhevsk, 426034
T. E. Chernyshova
Russian Federation
Tatiyana E. Chernyshova, department of the d octor of general practice and internal diseases with the ambulance course of the FAT and PR, professor, MD, PhD
281, st. Kommunarov, Republic of Udmurtia, Izhevsk, 426034
M. K. Ivanova
Russian Federation
Marina K. Ivanova, head of chair of the department of microbiology and virology, professor, MD, PhD
281, st. Kommunarov, Republic of Udmurtia, Izhevsk, 426034
A. A. Zhuikova
Russian Federation
Alina A. Zhuikova, department of faculty surgery, laboratory assistant
281, st. Kommunarov, Republic of Udmurtia, Izhevsk, 426034
References
1. Sharabchiev, Yu.T., Antipov V. V., Antipova S. I. [Comorbidity is an actual scientific and practical problem of the 21st century medicine]. Medicinskie novosti [Medical news], 2014, no 8 (239), pp. 6–11. (in Russ).
2. Konopleva T.N. [The defeat of the digestive system in diseases of the thyroid gland] Detskaya gastroenterologiya i problemy pediatrii: vchera, segodnya, zavtra, 1999, no 3, pp. 97–98. (in Russ).
3. Baryshnikova O. V. Clinical and functional characteristics of the state of the pancreas in hypothyroidism: Dissertation abstract for the degree of candidate of medical sciences. – Perm’, 2013. – 22s. (in Russ).
4. Rack S.K., Makela E. H. Hypothyroidism and depression: a therapeutic challenge. Ann Pharmacother. 2000. Vol. 34(10), pp. 1142‐1145. doi:10.1345/aph.10022.
5. Voronina T.A. [Antioxidant Mexidol. Main effects and mechanism of action]. Psihofarmakologiya i biologicheskaya narkologiya [Psychopharmacology and Biological Narcology], 2001, no. 1, pp. 2012. (in Russ).
6. Drozdova T.V., Fit’mova O.A., Fit’mova A.A. [The role of Mexidol in the treatment of moderate cognitive disorders in the manifestation of chronic cerebrovascular insufficiency]. Farmateka [Pharmateca], 2012, no. 14 (247), pp. 97–103. (in Russ).
7. Mazurov V.I., Bolotova M. E. [The role and place of Mexidol in the treatment of metabolic syndrome] RMZh [Russian medical journal], 2008, no. 15 (325), pp. 19–26.
8. Chefranov Zh. Yu., Makotrova T. A. [Mexidol in the complex therapy of ischemic stroke against the background of alcohol intoxication] Byulleten’ eksperimental’noj biologii i mediciny [Bulletin of Experimental Biology and Medicine], 2012, no. 1, pp. 73–76.
Review
For citations:
Chernyadeva E.V., Styazhkina S.N., Chernyshova T.E., Ivanova M.K., Zhuikova A.A. Possibilities of life quality correction of patients with chronic pancreatitis in postoperative hypothyroidis. Experimental and Clinical Gastroenterology. 2021;(11):21-27. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-195-11-21-27